Bovie Medical Corp. (BVX) Posts Mixed Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts BVX Hot Sheet
Price: $6.48 --0%
Financial Fact:
Research and development: 682K
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Research and development: 682K
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Bovie Medical Corp. (NYSE: BVX) reported Q4 EPS of ($0.08), versus $0.00 reported in the same period last year. Revenue for the quarter came in at $6.2 million, versus $5.5 million last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Tecnoglass (TGLS) Tops Q3 EPS by 2c ; Offers Guidance
- Sempra Energy (SRE) Tops Q3 EPS by 20c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
